Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DaVita HealthCare Partner (NY: DVA )

164.14 +2.74 (+1.70%)
Official Closing Price Updated: 7:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 707,757
Open 161.40
Bid (Size) 162.00 (1)
Ask (Size) 164.90 (2)
Prev. Close 161.40
Today's Range 161.38 - 164.87
52wk Range 97.31 - 168.50
Shares Outstanding 82,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul
Evolent Health, Kronos Bio, Saint-Gobain, Shell and Unilever are on the sell-side this week. Benzinga's Deal Dispatch has the latest M&A updates. 
Via Benzinga
Golden Years For M&A Deals Ahead Under Trump? Analysts Highlight Top 10 Large-Cap Candidates
GOP control of Congress under Trump could lead to a surge in M&A activity, especially in banks and biotech. Factors like equity market returns and rate cuts could fuel deals, with small-cap targets and... 
Via Benzinga
Topics Government
Exposures Political

Performance

YTD
+53.56%
+53.56%
1 Month
+1.61%
+1.61%
3 Month
+8.99%
+8.99%
6 Month
+21.81%
+21.81%
1 Year
+68.26%
+68.26%

More News

Read More
Why DaVita Stock Withered on Wednesday
Via The Motley Fool
What Analysts Are Saying About DaVita Stock
Via Benzinga
Key Takeaways From DaVita Analyst Ratings
Via Benzinga
6 Analysts Assess DaVita: What You Need To Know
Via Benzinga
Two Warren Buffett Stocks Get Pounded, With Apple Earnings Due
Via Investor's Business Daily
DaVita (DVA) Q3 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
3 Buy Rated Stocks Cruising At 52 Week Highs
Via Talk Markets
AdaptHealth Stock Earns RS Rating Upgrade
Via Investor's Business Daily
3 Red Hot Stocks Flashing Buy Signals: DaVita, Intuitive Surgical, SharkNinja
Via Talk Markets
Bull Of The Day: Davita - Friday, September 6
Via Talk Markets
Top Medical Stocks To Hedge Against The September Effect
Via Talk Markets
Topics Economy
Exposures Interest Rates
Nvidia is Down 21%. Here Are 3 Better Stocks to Buy for the Rest of 2024
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
DaVita (DVA) Q2 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
DVA Stock Earnings: DaVita Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Financial Crime Weekly: DaVita Agrees To Pay $34.5M For Kickbacks, Hospice Provider Doles Out $19.4M For False Claims
Via Benzinga
2 Warren Buffett Stocks to Buy Hand Over Fist and 1 to Avoid
Via The Motley Fool
Buffett Buys on a Budget: The 3 Cheapest Stocks Held by Berkshire Hathaway
Via InvestorPlace
These Warren Buffett Stocks Are Trouncing the S&P 500 so Far This Year. Are They Still Buys?
Via The Motley Fool
Topics Stocks
Exposures US Equities
Fresenius SE's Future With Dialysis Company Unclear, Investors Seek Answers
Via Benzinga
Tandem Diabetes Catapults Above A Profit-Taking Zone, But DaVita Reverses, Nearly Triggering A Sell Signal
Via Investor's Business Daily
The Big Split: 3 Stock Spinoffs Are Coming. Should You Buy?
Via InvestorPlace
DaVita (DVA) Q1 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.